Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

(2014) S. Saab et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network

(2014) Forough Sargolzaee Aval et al.   Hepatitis Monthly

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

(2014) Salvatore Petta et al.   HEPATOLOGY

Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C

(2014) H. Leleu et al.   JOURNAL OF VIRAL HEPATITIS

Direct Medical Care Costs Associated With Patients Diagnosed With Chronic HCV

(2013) Sara Ashtari et al.   Hepatitis Monthly

Sofosbuvir Has Come Out of the Magic Box

(2013) Seyed Moayed Alavian   Hepatitis Monthly

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

(2013) Kris V Kowdley et al.   LANCET